Filing Details

Accession Number:
0001415889-24-030109
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-23 19:53:44
Reporting Period:
2024-12-20
Accepted Time:
2024-12-23 19:53:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1192448 Glaukos Corp GKOS Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1293171 H Gilbert Kliman C/O Glaukos Corporation
One Glaukos Way
Aliso Viejo CA 92656
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-12-20 10,000 $32.00 42,336 No 4 M Direct
Common Stock Disposition 2024-12-20 10,000 $150.28 32,336 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-12-20 10,000 $0.00 10,000 $32.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-07-23 No 4 M Direct
Footnotes
  1. Includes 2,611 restricted stock units that have not vested or been delivered to the Reporting Person.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2024.
  3. This transaction was executed in multiple trades at prices ranging from $150.00 to $150.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2024.
  5. This option was granted on July 23, 2015 and has a three-year vesting schedule in which one-third vests on each of the first three anniversaries of the grant date, such that the stock option vests in full on the three-year anniversary of the grant date.